Inspire’s neurostimulator for obstructive sleep apnoea therapy gains FDA approval
According to GlobalData, the market for neurological devices was valued at $12.5bn in 2023 and is expected to grow by a CAGR of 4.60% to reach $20.9bn by 2033.
According to GlobalData, the market for neurological devices was valued at $12.5bn in 2023 and is expected to grow by a CAGR of 4.60% to reach $20.9bn by 2033.